BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27429043)

  • 1. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
    Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
    Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
    Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
    EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
    Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
    J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.
    Sakata J; Sasayama T; Tanaka K; Nagashima H; Nakada M; Tanaka H; Hashimoto N; Kagawa N; Kinoshita M; Nakamizo S; Maeyama M; Nishihara M; Hosoda K; Kohmura E
    J Neurooncol; 2019 Apr; 142(2):241-251. PubMed ID: 30701354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of annexin A family in glioblastoma.
    Xu H; Wu X; Dou Y; Zheng W
    Ir J Med Sci; 2022 Aug; 191(4):1539-1547. PubMed ID: 34398393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
    Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
    PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.
    Li X; Nie S; Lv Z; Ma L; Song Y; Hu Z; Hu X; Liu Z; Zhou G; Dai Z; Song T; Liu J; Wang S
    Cell Death Dis; 2021 Mar; 12(3):261. PubMed ID: 33712571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
    Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.